In 2020, researchers Jian Sun, Xiaoqin Huang et al, in the Laboratory of Immunology at the National Eye Institute, confirmed in the lab what has been going on in human ophthalmology in recent years, but with a twist. Their deep learning model enabled identification of retinal disease stages with noteworthy accuracy. What marked their work
29.11
2021
Phoenix MICRON Spins out of Phoenix Technology Group to Better Serve Eye and Eye-Brain Researchers Globally
Bend, OR, USA, November 29, 2021 — The newly formed company, Phoenix-Micron, Inc., announced today it has completed the spin-out of the Phoenix MICRON® imaging platform from Phoenix Technology Group. This move is designed to increase focus and innovation in products designed to serve the eye and eye-brain research community. The new company, Phoenix-Micron, Inc.
19.10
2021
Cataracts caused by lens protein knockout imaged using the Phoenix MICRON® IV Slit Lamp
In their article, “CRYβA3/A1-Crystallin Knockout Develops Nuclear Cataract and Causes Impaired Lysosomal Cargo Clearance and Calpain Activation,” Hegde et al use the Phoenix MICRON® IV Slit Lamp to examine the effect of knocking out a lens structural protein. α, β and γ crystallins are lens structural proteins that are needed for transparency and refractive power
30.08
2021
Creative use of the Phoenix MICRON® system to study corneal wound healing
Hampel et al use the Phoenix MICRON® III imaging platform in an unusual manner in their paper “Relaxin 2 is functional at the ocular surface and promotes corneal wound healing by visualizing enucleated corneas.” The Phoenix MICRON® is designed to take crisp images and videos of the rodent retina, but this article demonstrates the other
29.07
2021
Subretinal injection damage has implication for experimental control and treatment in rat model of retinopathy of prematurity
In their 2017 article, “Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model,” Becker et al used the Phoenix MICRON® IV fundus camera, Phoenix MICRON® OCT2 and corresponding layer analysis software Insight 2D, and the Phoenix MICRON® focal ERG to find that subretinal injection of saline or even introduction
24.06
2021
Promising treatment for retinal inflammation studied with the Phoenix MICRON® OCT and exclusive analysis software Insight 2D
In their paper, “Connexin43 Mimetic Peptide Improves Retinal Function and Reduces Inflammation in a Light-Damaged Albino Rat Model,” Guo et al promoted neuroretinal survival in a light damage paradigm by blocking the Connexin43 hemichannels. Using the Phoenix MICRON® OCT to examine the structure of the retina at precise retinal locations as shown by the bright